Intrathecal Injection of Gammaglobulin in the Treatment of Severe Forms of Meningitis

  • H. E. Diemath
  • J. Strohecker
Conference paper
Part of the Advances in Neurosurgery book series (NEURO, volume 9)


In the course of the past five years 23 patients were treated with intrathecal gammaglobulins for severe posttraumatic or postoperative meningitis. Ten patients had posttraumatic, and ten had a postoperative infection, while three more suffered from cerebral abscesses. In all patients, the infection had occurred in spite of prophylactic treatment with antibiotics. We were able to effect a speedy reduction of the cell count in the cerebrospinal fluid accompanied by an improvement in the patients general condition, followed by a complete cure only after intrathecal injections of between 250 and 500 mg per day of enzymatically decomposed gammaglobulin (Gammavenin TM).


Intrathecal Injection Aureus Staph Airborne Bacterium Cerebral Abscess Intrathecal Treatment 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Ax, W., Kanzy, E. J., Goronzi, B., Seiler, F.R.: Beeinflussung in vitro Phagozytose und in vivo Bakterienelimination durch Immunserum, IgG und den verschiedenen daraus hergestellten IgG-Frag- menten. Proceedings of the Deutsche Gesellschaft für Innere Medizin, Vol. 84. München: Bergmann 1978Google Scholar
  2. 2.
    Barandum, S., Skvaril, F., Morell, A.: Prophylaxe und Therapie mit Gammaglobulinen. Schweiz. Med. Wschr. 106, 533–580 (1976)Google Scholar
  3. 3.
    Johannsen, R., Enders, B., Seiler, F.R.: Haemolytic and lympholytic properties of F(ab')2 fragments of antibodies: Activation of complements via the alternate pathway. Z. Immun. Forsch. 153,313 (1977)Google Scholar
  4. 4.
    Koch, F.: Erste Erfahrungen mit Gamma-Venin, einem intravenös injizierbaren Gammaglobulin-Präparat in der Kinderheilkunde. Dtsch. Med. Wschr. 88, 282 (1963)PubMedCrossRefGoogle Scholar
  5. 5.
    Lang, W.: Die intravenöse Gammaglobulin-Therapie. Dtsch. Med. Wschr. 89, 2374 (1964)PubMedCrossRefGoogle Scholar
  6. 6.
    Llewellyn, R.C., Jarrott, D.M., Meriwether, R.P.: Intraoperative prophylactic therapy: A prospective study of the effectiveness, cost and complications. In: Advances in neurosurgery, Vol. 7, Marguth, F., Brock, M., Kazner, E., Klinger, M., Schmiedek, P. (eds.), pp. 371–375. Berlin, Heidelberg, New York: Springer 1979Google Scholar
  7. 7.
    Richling, B.: Erfahrungen mit der intrathekalen Gammaglobulin-therapie. Der Nervenarzt 48, 449 (1977)PubMedGoogle Scholar
  8. 8.
    Zwisler, O., Joachim, I.: Ampicillinresistente Mutanten von Staph, aureus durch Gammaglobulin reduziert. Diagnostik und Intensivtherapie 2, 11–14 (1978)Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1981

Authors and Affiliations

  • H. E. Diemath
  • J. Strohecker

There are no affiliations available

Personalised recommendations